Suraksha Diagnostic informs about credit rating migration

09 Oct 2025 Evaluate

Pursuant to Regulation 30 read with Clause 3 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suraksha Diagnostic has informed that Crisil Ratings (‘Crisil’), has migrated the rating on the long-term bank facilities of the Company from 'Crisil B (Issuer Not Cooperating) / Stable' to ‘Crisil A- / Stable’ and has assigned its ‘Crisil A2+’ rating on the short-term bank facilities of the Company on 08 October 2025. The rating rationale has been uploaded on Crisil’s website and please note that this information shall also be made available at the Company’s website at www.surakshanet.com.

The above information is a part of company’s filings submitted to BSE.  


Suraksha Diagnostic Share Price

281.85 1.20 (0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×